Abstract
We have noted that human immunodeficiency virus (HIV)-seropositive patients who develop adipose redistribution (AR) while receiving combination antiretroviral therapy (ART) also tend to have a better response to ART, as indicated by the relative change in CD4 percent compared to those who don't develop AR on therapy. Whether the possible benefits of the improved CD4 response outweigh the metabolic and cosmetic problems associated with lipodystrophy is not known.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1497-1498 |
| Number of pages | 2 |
| Journal | Clinical Infectious Diseases |
| Volume | 31 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2000 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Adipose redistribution in human immunodeficiency virus-seropositive patients: association with CD4 response'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS